Jun 2026Revenue $742K/yrExpenses $45.7M/yr
No trendCash runway ≈ 3 months from Jun 2026
Figures by year
When will BioXcel Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $742K and expenses $45.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $642K | $51.1M | −$50.5M |
| Dec 2024 | $2.27M | $69.5M | −$67.2M |
| Dec 2023 | $1.38M | $173M | −$172M |
| Dec 2022 | $375K | $160M | −$160M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.